Skystar Bio - Pharmaceutical Company (SKBI)
Skystar Bio - Pharmaceutical Company Cash and ST Investments: 7.04M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SKBI Cash and ST Investments Rankings
| Overall | 12th percentile | 3817 of 4370 |
| Sector | 11th percentile | 448 of 506 in Healthcare |
| Industry | 12th percentile | 22 of 25 in Drug Manufacturers - Major |
SKBI Cash and ST Investments Range, Past 5 Years
| Minimum | 2.03M | Sep 2010 |
| Maximum | 7.40M | Mar 2011 |
| Average | 5.07M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these SKBI related companies
SKBI News
$SKBI forms bullish "Bottom Triangle" chart pattern. http://stks.co/3PIs
about 43 days ago by RecogniaEvents
about 43 days ago by RecogniaEvents
Skystar Bio-Pharmaceutical Reports Record Fiscal Year 2011 Financial Results
Apr 02, 6:30AM Marketwire
Apr 02, 6:30AM Marketwire
Skystar to File Audited Financial Results for Full Fiscal Year 2011 on Friday, March 30, 2012
Mar 29, 8:30AM Marketwire
Mar 29, 8:30AM Marketwire
NASDAQ Panel Grants Skystar's Request for Continued Listing on NASDAQ Stock Market
Mar 27, 8:30AM Benzinga
Mar 27, 8:30AM Benzinga
$SKBI receives Nasdaq panel date of March 1. Delisting stayed for now. http://stks.co/21VG
about 132 days ago by TradeHawk
about 132 days ago by TradeHawk
Nasdaq to initiate proceedings to delist China stock $SKBI Skystar Bio-Pharm Monday morning. http://stks.co/20ww
about 132 days ago by TradeHawk
about 132 days ago by TradeHawk
Skystar Bio-Pharmaceutical Announces Revenue of $20.9 Million for Third Quarter Fiscal Year 2011
Nov 14, 6:35PM Marketwire
Nov 14, 6:35PM Marketwire
Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw Annual Global Investment Conference
Sep 06, 11:07AM Marketwire
Sep 06, 11:07AM Marketwire
Skystar Bio Pharmaceutical Co. (SKBI) Reports Q2 Earnings of $0.21; Guides FY11 Revs
Aug 22, 5:41PM Street Insider
Aug 22, 5:41PM Street Insider
$CNIT, $ZSTN, $SKBI, $SIHI continue to have good long term setups
about 315 days ago by davidsalamon
about 315 days ago by davidsalamon
Skystar Bio-Pharma backs 2011 revenue view of $60M-$63M vs. consensus $62.62M
May 24, 6:07AM FlyOnTheWall
May 24, 6:07AM FlyOnTheWall
taking small long in $SKBI 10.48, starting to breakout on daily, when this gets volume, tends to make big moves
about 512 days ago by stockmannick
about 512 days ago by stockmannick
China smallcaps on my watchlist today, earnings for $SKBI and $PWRD, watching $16 level for support in $CCME
about 562 days ago by stockmannick
about 562 days ago by stockmannick
couple of China small caps that are breaking out on daily chart are $CMFO and $SKBI
about 591 days ago by stockmannick
about 591 days ago by stockmannick
long $SKBI, another low float china play breaking out of Daily Chart, one to watch $$
about 594 days ago by stockmannick
about 594 days ago by stockmannick
$SKBI completed a White Hammer candlestick pattern on 09/17/2010. Look for an upward price movement on 09/18/2010
about 622 days ago by candlestickpick
about 622 days ago by candlestickpick
$SKBI completed a White Hammer candlestick pattern on 09/17/2010. Look for an upward price movement on 09/18/2010
about 622 days ago by candlestickpick
about 622 days ago by candlestickpick
$SKBI completed a White Hammer candlestick pattern on 09/17/2010. Look for an upward price movement on 09/18/2010
about 622 days ago by candlestickpick
about 622 days ago by candlestickpick
$SKBI completed a White Hammer candlestick pattern on 09/17/2010. Look for an upward price movement on 09/18/2010
about 622 days ago by candlestickpick
about 622 days ago by candlestickpick
$SKBI completed a White Hammer candlestick pattern on 09/17/2010. Look for an upward price movement on 09/18/2010
about 622 days ago by candlestickpick
about 622 days ago by candlestickpick
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SKBI | 2.32 | -0.07 | -2.93% | 16.61M |
| SJW | 23.07 | +0.05 | +0.22% | 428.63M |
| SJT | 13.60 | -1.18 | -7.98% | 688.90M |
| SJR | 18.92 | -0.08 | -0.42% | 7.936B |
| SB | 6.41 | +0.02 | +0.31% | 485.00M |
| SAVE | 20.52 | -0.11 | -0.53% | 1.396B |
| SATS | 28.00 | +0.18 | +0.65% | 2.411B |
| SATC | 0.3387 | -0.01 | -3.37% | 46.24M |
| SASR | 17.70 | +0.17 | +0.97% | 422.47M |
| SAPX | 0.057 | +0.00 | +2.15% | 2.005M |
